CMR Surgical Launches a Virtual Reality Headset & VR Professional Education Program for the Versius® Surgical Robotic System

CMR Surgical notes Versius becomes the first soft-tissue surgical robotics system to offer VR training as part of its surgical team training pathway; giving surgical teams increased flexibility to practice their skills.

The Versius Virtual Reality headset is wireless, doesn’t require connecting to a PC and is packaged within a small box for portability and convenience.

Simulating a lifelike and immersive experience, Versius Virtual Reality mimics the real-life environment of an operating room. Users are guided through learning objectives by a virtual assistant to support them at every step. There is also the opportunity to collaborate alongside other surgical team members in the virtual environment.

Versius Virtual Reality will be launched in pilot hospitals from June 2022, with global roll out is expected from late Summer 2022.

CMR Surgical has produced Versius Virtual Reality in partnership with FundamentalVR, a leading virtual reality education platform, and will continue to develop the programme in collaboration with surgical teams.

The new VR programme will complement the existing proficiency-based professional education programme for Versius, including the Versius Simulator and remote learning options.

Fiona Morrison, Global Head of Professional Education, CMR Surgical says: “Our professional education programmes are always focused on optimising the use of Versius for surgical teams. It is exciting to add a virtual reality element to our already comprehensive and well-respected courses. Now, surgeons, nurses and the entire surgical team will be able to develop their skills with Versius, when and where it’s convenient for them. The virtual environment is so realistic that even if you’re sat practicing at home, you really feel like you are in the operating room.”

The Versius® Surgical Robotic System

Versius® resets expectations of robotic surgery. Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS). The small, portable and modular design of Versius allows the surgeon to only use the number of arms needed for a given procedure.

Biomimicking the human arm, Versius gives surgeons the choice of optimised port placement alongside the dexterity and accuracy of small fully-wristed instruments. With 3D HD vision, easy-to adopt instrument control and a choice of ergonomic working positions, the open surgeon console has the potential to reduce stress and fatigue and allows for clear communication with the surgical team. By thinking laparoscopically and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value that robotic MAS brings.

But it’s more than just a robot. Versius captures meaningful data with its wider digital ecosystem to support a surgeon’s continuous learning. Through the Versius Connect app, Versius Trainer and CMR clinical registry, Versius unleashes a wealth of insights to ultimately improve surgical care.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version